Analytical and Bioanalytical Chemistry 2008-10-01

Thermoresponsive polymeric gel as a medium for examining interactions between dsDNA and an anticancer drug.

Agata Kowalczyk, Anna M Nowicka, Marcin Karbarz, Zbigniew Stojek

Index: Anal. Bioanal. Chem 392(3) , 463-9, (2008)

Full Text: HTML

Abstract

A piece of dry N-isopropylacrylamide polymer was soaked in phosphate buffer to obtain a hydrogel which was then employed in the examination of interactions between an anticancer drug C-1311 (5-diethylaminoethyl-amino-8-hydroxyimidazoacridinone) and dsDNA. dsDNA was introduced into the polymer at the polymerization stage. The drug was added to the buffer. Using the volume phase transition of the gel at 40 degrees C, the unbound drug could be determined in the solution released during the transition, which made the calculations more reliable. The interaction parameters were calculated using the McGhee and von Hippel model. It appeared that in the gel medium, the interaction between the drug and dsDNA is spatially limited, since the number of binding units of the polymer chain occupied by one drug molecule was found to be one, while it was two in the regular buffer solution.

Related Compounds

Related Articles:

DNA-damaging imidazoacridinone C-1311 induces autophagy followed by irreversible growth arrest and senescence in human lung cancer cells.

2013-09-01

[J. Pharmacol. Exp. Ther. 346(3) , 393-405, (2013)]

Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.

2013-02-01

[Drug Metab. Dispos. 41(2) , 414-21, (2013)]

Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.

2005-09-01

[J. Pharm. Biomed. Anal. 39(1-2) , 46-53, (2005)]

Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells.

2011-12-01

[Xenobiotica 41(12) , 1044-55, (2011)]

Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.

2011-10-01

[Cancer Biol. Ther. 12(7) , 586-97, (2011)]

More Articles...